What changed
$MDLZ — Makes snacks and confectionery products globally.
🎯 Q1 FY26 | Rev $10B | EPS $0.67 vs $0.61 🟢 | Margin 11.4%
💡 Consensus expects MDLZ to benefit from stable consumer staples demand and cost discipline. However, the Q1 beat was driven by a 10.2% EPS surprise, yet operating income fell 19.3% YoY and free cash flow collapsed to $155M from $815M a year ago. The market is overlooking deteriorating cash generation and margin compression.
🏢 Business Quality: 7/10 | Valuation: fair
📉 Reward/Risk: Upside 10% to $70 (consensus target) vs downside 15% to $55 (if FCF guidance cut). Ratio 0.67:1, unfavorable.
🔮 Catalyst: Q2 2026 earnings (late July): FCF trajectory and margin recovery. Key metric: operating cash flow vs. $3B annual FCF run-rate. Failure signal: operating cash flow below $1.5B in H1.
💰 Entry: Current price $64.18 is near fair value.
Also in play: $K $HSY $CPB $GIS $CAG $ADM